MOSSERI MARLIO CHARLES purchased 1.0% of their position (27.41K shares) of NUVECTIS PHARMA, INC. on the open market
Open‑market purchase worth $235.6K — a small addition. The strongest form of insider conviction signal.
Common Stock
Shares
+2.34K
Price / share
$8.40
Trade value
$19.66K
% of position
Common Stock
Shares
+10.10K
Price / share
$8.64
Trade value
$87.30K
% of position
Common Stock
Shares
+2.70K
Price / share
$8.40
Trade value
$22.71K
% of position
Common Stock
Shares
+9.61K
Price / share
$8.64
Trade value
$83.06K
% of position
Common Stock
Shares
+50.00
Price / share
$8.65
Trade value
$432.50
% of position
Common Stock
Shares
+100.00
Price / share
$8.65
Trade value
$865.00
% of position
Common Stock
Shares
+100.00
Price / share
$8.65
Trade value
$865.00
% of position
Common Stock
Shares
+2.40K
Price / share
$8.65
Trade value
$20.76K
% of position
Net shares
+27.41K
Net value
$235.65K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 5/6/2025 | P · Purchase | +2.34K | $8.40 | $19.66K | 0.1% | 2.88M | 2.89M |
| Common Stock Indirect | 5/6/2025 | P · Purchase | +10.10K | $8.64 | $87.30K | 0.4% | 2.89M | 2.90M |
| Common Stock Indirect | 5/7/2025 | P · Purchase | +2.70K | $8.40 | $22.71K | 0.1% | 2.90M | 2.90M |
| Common Stock Indirect | 5/7/2025 | P · Purchase | +9.61K | $8.64 | $83.06K | 0.3% | 2.90M | 2.91M |
| Common Stock Indirect | 5/8/2025 | P · Purchase | +50.00 | $8.65 | $432.50 | 0.0% | 2.91M | 2.91M |
| Common Stock Indirect | 5/8/2025 | P · Purchase | +100.00 | $8.65 | $865.00 | 0.0% | 2.91M | 2.91M |
| Common Stock Indirect | 5/8/2025 | P · Purchase | +100.00 | $8.65 | $865.00 | 0.0% | 2.91M | 2.91M |
| Common Stock Indirect | 5/8/2025 | P · Purchase | +2.40K | $8.65 | $20.76K | 0.1% | 2.91M | 2.91M |
| Total | +27.41K | $235.65K | ||||||